Mkts

Aldeyra Therapeutics, Inc.

NASDAQ: ALDX
$0.64-0.01 (-1.47%)
As of Oct 23, 3:52 PM ET

Key statistics

Day range
0.600.65
52-week range
0.635.93
Today
Open0.63
Previous close0.64
Volume5.45M
Valuation
Market cap38.93M
P/E ratio—
EPS (TTM)-0.38
Income & risk
Dividend / yield—
Beta1.25
Avg volume1.38M
Discussion

ALDX News

Stories mentioning ALDX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development2,4104,3045,4318,5057,42314,62912,44214,970
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(3,547)(6,668)(8,001)(10,169)(10,427)(16,577)(16,138)(18,008)
Interest Income563.00682.00789.00872.00981.001,2401,5041,638
Interest Expense478.00
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(3,453)(6,462)(7,688)(9,767)(9,930)(15,808)(15,113)(16,848)
Earnings Per Share (Basic)(0.06)(0.11)(0.13)(0.16)(0.17)(0.27)(0.25)(0.28)
Earnings Per Share (Diluted)(0.06)(0.11)(0.13)(0.16)(0.17)(0.27)(0.25)(0.28)
Weighted Average Shares Outstanding (Basic)60,31960,05760,12760,04659,88759,48559,53059,414
Weighted Average Shares Outstanding (Diluted)60,31960,05760,12760,04659,88759,48559,53059,414

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ALDX

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is a stock listed on the Nasdaq Stock Market under the ticker symbol ALDX. It last traded at $0.6400 (Oct 23, 2026, 3:52 PM ET), down 1.5% on the day. That gives Aldeyra Therapeutics a market capitalisation of $38.9M.

Over the past 52 weeks ALDX has traded between $0.6300 and $5.93.

For the quarter ended Mar 31, 2026 it reported a net loss of $3.5M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$3.5M
Dec 31, 2025—-$6.5M
Sep 30, 2025—-$7.7M
Jun 30, 2025—-$9.8M

From Aldeyra Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…